Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of gastroenterology and hepatology"
DOI: 10.1111/jgh.15837
Abstract: BACKGROUND AND AIM Duodenal ulcers, especially caused by increasingly drug-resistant Helicobacter pylori, are a concern in Asia. We compared oral vonoprazan versus lansoprazole for efficacy (healing duodenal ulcers), and safety in non-Japanese Asian patients. METHODS… read more here.
Keywords: non inferior; inferior lansoprazole; helicobacter pylori; asian patients ... See more keywords